News

Kepler Capital Maintains a Hold Rating on GSK plc (GSK)

GSK plc (NYSE:GSK) is one of the best growth stocks under $50 to buy now. In a report released on September 4, David Evans ...
Fierce Pharma6d

Seeking royalties, GSK expands mRNA patent litigation to include Moderna's next-generation COVID shot

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. | ...

TD Cowen Maintains a Hold Rating on GSK plc (GSK), Sets a PT of $45

GSK plc (NYSE:GSK) is one of the best UK stocks to buy right now. On September 2, TD Cowen analyst Steve Scala maintained a Hold rating on GSK plc (NYSE:GSK) and set a price target of $45.00. The ...

GSK's RSV Vaccine Arexvy Included in Publicly Funded Prevention Programs for Older Adults in Canada

GSK announced today that Arexvy (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) will be offered through ...

GSK begins shipping influenza vaccine doses for the 2025- 26 flu season in Canada

GSK Canada (GlaxoSmithKline Inc.) today announced it has started shipping doses of its trivalent seasonal influenza vaccine, ...

Closed factory's £2m fund backs local projects

A £2m fund set up by a pharmaceutical giant after it decided to close a factory has awarded cash to a charity-run park and a community space offering help to residents. Last year, GlaxoSmithKline (GSK ...